IMRN Immuron Limited ADRs

Immuron Ltd is a biopharmaceutical company which develops polyclonal antibodies for the treatment and prevention of diseases. It products include Travelan, IMM-124E for NASH and IMM-529 for Clostridium difficile infection. This is an ADR of a company whose stock trades outside of the U.S. as the symbol AT:IMC.

$4.85  +0.02 (0.42%)
As of 05/26/2021 16:00:00 EST     IEX book   CBOE book


Security Information
Category1:  US Equity
Category2:  ADRs
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  Australia
Country of incorporation:  Australia
IPO date:  06/09/2017
Outstanding shares:  5,681,165
Average volume:  12,207
Market cap:   $27,554,218
Current dividend yield:  0.00%
All SEC filings:   SEC Edgar Online
Annual filings:      20-F
CUSIP:    45254U101
ISIN:        US45254U1016
Sedol:      
Valuation   (See tab for details)
PE ratio:   0.00
PB ratio:   0.97
PS ratio:   0.00
Return on equity:   0.00%
Net income %:   0.00%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy